Investor Ideas
Potcasts: Interview with Kaya Holdings (OTCQB: KAYS) on the Sacred
Mushroom Center - Pioneers with Psilocybin and Advocates for Mental
Health
November 28, 2023
-- InvestorsHub NewsWire -- via (Investorideas.com
Newswire),
Investorideas.com, a global news source
covering leading sectors including marijuana and psychedelic stocks
releases a special edition of the top rated
Investor Ideas
potcast (Cannabis
Podcast).
In today's episode,
Investor Idea's host Cali Van Zant speaks with CEO Craig Frank and
Senior Consultant Dave Jones of Kaya Holdings Inc
(OTCQB:
KAYS).
Listen to the
podcast:
https://www.investorideas.com/Audio/Podcasts/2023/112223-Cannabis.mp3
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Kaya Holdings, Inc. is a
mind care company focusing on wellness and mental health through
their operations in medical and recreational cannabis, CBD products
and psychedelic treatment clinics.
Kaya has the historical
distinction of being the first US publicly traded company to hold
and operate cannabis licenses in "touch the plant" categories from
when it commenced cannabis operations in Portland, Oregon in
2014.
In today's podcast,
management discusses the new opportunities in the medical
psychedelic market and how Kaya Holdings is leading the way as an
innovator and pioneer in the sector. They also talk about their
recent milestone of opening one of the first state licensed
Psilocybin Treatment Centers in the United States, in Portland,
Oregon.
Host Cali Van Zant says,
"What makes this podcast special is to hear management go deep and
share their personal experiences and show that they care about
community. We discuss mental health and how it
personally affects
us all. It is a rare opportunity to get such personal insight from
a management team and the opportunity to find a
public company with heart. I hope you all enjoy listening and share
this interview."
To learn more about Kaya
holdings you can visit their website at
(www.kayaholdings.com) or reach out to
the team at
info@kayaholdings.com
Today's podcast
overview
When
talking about the new Sacred Mushroom space,
CEO Craig Frank
notes, "It is very important to us that the
facility be in a central location because we think community is a
big part of the healing process. We were very lucky to find the
perfect location."
"The space is the
entire top floor of the Falcon Building in downtown Portland. At
about 11,000 square feet, we have the area we need to offer both
private and group experiences, as well as creativity centers,
sensory rooms, reflection areas, and the room to roam and explore.
We are equipped with a full kitchen and will be able to provide
food consistent with Oregon regulation….
I think there are
four primary differences between us and what we have seen so far. I
would say the first difference is the space itself. A huge
contributing factor in the quality of an experience is the setting
and ours is extraordinary. Another difference would be the extent
to which we aim to cater the journey to individual preference, with
sound, sight, and scent options and the activity options presented.
Third, I would say the community we seek to create. While we will
cater to out-of-state visitors, our emphasis is on serving the
needs of the Greater Portland area. Finally, I would say our
pricing model is different. We are aiming to enable sustained
treatment to those who seek it, so we have some less expensive
microdosing options."
When
talking about other companies in the psilocybin
space, he went on to say,
"The work of companies like ATAI Life Sciences
and Compass Pathways is fascinating and we are excited to see what
their research can teach all of us about the medicinal
possibilities of psilocybin.
CMPS is developing
its own synthetic versions of that they then plan to administer in
their own treatment facilities. Our model calls for the use of
natural psilocybin and psilocin in our own
facilities. We believe our
model is more immediate and allows us to avoid the long, laborious,
and very costly FDA process. We expect to begin offering treatments
immediately upon licensing of our facility…"
When
talking about the personal reasons for building a treatment center
and working in the Psilocybin
space, Frank
says, "I would say that
it is hard to find an American family that does not have someone
with a mental disorder effecting their personal story whether it be
a sibling, a parent, a child, or a friend. There is something in
the way we live that causes profound pain and disorder in some
people and our involvement is in some ways motivated to bring this
relief; to those we love and those other people love."
About Kaya Holdings, Inc.
(www.kayaholdings.com
)
Kaya
Holdings, Inc is a "mind care" company with operations in
medical/recreational cannabis and pending operations in the
emerging psilocybin sector. KAYS is a fully reporting, US-based
publicly traded company, listed for trading on the over-the-counter
market under the symbol KAYS.
In
2014, KAYS became the first US public company to own and operate a
medical cannabis dispensary (in Portland, Oregon). The Company
still operates the original Kaya Shack™ cannabis dispensary while
seeking to shift our cannabis operations to serve the European
Union. KAYS has interests in three medical cannabis licenses (2 in
Greece, 1 in Israel) to advance this effort.
Resuming its role as innovator and trend setter, the Company is
again breaking ground in the United States with the planned
introduction of psilocybin treatment centers through our majority
owned subsidiary, Fifth Dimension Therapeutics, Inc. ("FDT").
About Investorideas.com - Big Investing
Ideas
Investorideas.com
is a platform for investing ideas. We publish breaking stock
news, stock research, guest posts and create original top rated
investing podcasts, plus sector tag articles featuring up and
coming companies and industry leaders. Investor Idea's
original branded content includes the Crypto Corner
Podcast , Play by Play Sports
Podcast , Cannabis News and Stocks
on the Move Podcast ,
Cleantech and Climate
Change Podcast,
Exploring Mining
Podcast , Betting on Gaming Stocks
Podcast and the AI Eye
Podcast. We also create free investor
stock directories for AI and tech, biotech, cannabis, cleantech,
crypto, defense, gaming, health and wellness, mining, oil and gas,
sports and water.
To hear more Investorideas.com podcasts
visit: https://www.investorideas.com/Audio/.
The Investorideas.com podcasts are also
available on iTunes (Apple Podcasts), Audible, Spotify, Tunein,
Stitcher, Spreaker.com, iHeartRadio, Google Podcasts and most audio
platforms available.
Disclaimer/Disclosure: Investorideas.com
is a digital publisher of third party
sourced news, articles and equity research as well as creates
original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright
laws other than syndication rights. Our site does not make
recommendations for purchases or sale of stocks, services or
products. Nothing on our sites should be construed as an offer or
solicitation to buy or sell products or securities. All investing
involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and
marketing, content creation and more. Disclosure: KAYS is a paid
for monthly featured stock on Investorideas.com. Contact management
and IR of each company directly regarding specific questions. More
disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services
on the Investorideas.com newswire https://www.investorideas.com/News-Upload/
and tickertagstocknews.com
Global investors must adhere to
regulations of each country. Please read Investorideas.com privacy
policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use
of cannabis except where permissible by law. Our site does not
possess, distribute, or sell cannabis products.
Learn more about sponsoring this podcast or be a guest and our
other branded content opportunities at
Investorideas.com
Follow us on
Twitter https://twitter.com/Investorideas
Follow us on
Facebook https://www.facebook.com/Investorideas
Follow us on
YouTube https://www.youtube.com/c/Investorideas
Contact
Investorideas.com
800 665
0411
SOURCE: Investorideas.com